DtP a Covid-19 Solution or a Long-Term Change to Clinical Trial Conduct? (WS21)
- Date:
- 29 April 2021
- Time:
- -
- Available Seats:
- 50
Expanding access to patient populations, faster recruitment, increasing patient retention and decreasing time to market are all reasons sponsors shifted to direct-to-patient and decentralized clinical trials. This workshop will focus on the positive aspects and outcomes of the amazing pivot that the industry accomplished in adopting these new models.
